Mimedx (MDXG) Total Debt Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -5.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.70% |
| Dec 31, 2025 | -4.58% |
| Sep 30, 2025 | -4.23% |
| Jun 30, 2025 | -9.72% |
| Mar 31, 2025 | -4.09% |
| Dec 31, 2024 | -61.65% |
| Sep 30, 2024 | -61.16% |
| Jun 30, 2024 | -58.13% |
| Mar 31, 2024 | -60.07% |
| Dec 31, 2023 | 1.04% |
| Sep 30, 2023 | 1.01% |
| Jun 30, 2023 | 1.00% |
| Mar 31, 2023 | 0.98% |
| Dec 31, 2022 | 0.97% |
| Sep 30, 2022 | 0.96% |
| Jun 30, 2022 | 0.94% |
| Mar 31, 2022 | 0.92% |
| Dec 31, 2021 | 0.90% |
| Sep 30, 2021 | 0.81% |
| Jun 30, 2021 | -26.55% |
| Mar 31, 2021 | -26.90% |
| Dec 31, 2020 | -27.35% |
| Sep 30, 2020 | -27.75% |
| Jun 30, 2020 | -2.39% |
| Jun 30, 2017 | 82.27% |
| Sep 30, 2012 | -7.45% |
| Jun 30, 2012 | 26,408.63% |